Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.77 +0.03 (+4.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Non-Current Debt (2016 - 2017)

Updated

Creative Medical Technology Holdings (CELZ) posted Non-Current Debt of $100,000 for Q4 2019.

Analysis

Creative Medical Technology Holdings (CELZ) Non-Current Debt (2016 - 2017) Analysis & Trends

For FY2019, Creative Medical Technology Holdings' Non-Current Debt came in at $50,000.

  • The Q4 2019 figure stands as the lowest quarterly Non-Current Debt since Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 62.48 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 23.83 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 60.50 Bn
10 Creative Medical Technology Holdings 1.02 Mn -25.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 25,000.00
Dec 31, 2016 25,000.00
Sep 30, 2016 25,000.00
Jun 30, 2016 69,031.00
Mar 31, 2016 18,200.00
API Access

Creative Medical Technology Holdings Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CELZ&period=max&api_key=YOUR_API_KEY